Parag Foods Q1 PAT seen up 48.8% YoY to Rs. 15.7 cr: KR Choksey

KR Choksey has come out with its first quarter (April-June�� 18) earnings estimates for the FMCG sector. The brokerage house expects Parag Foods to report net profit at Rs. 15.7 crore up 48.8% year-on-year (up 40.1% quarter-on-quarter).

Net Sales are expected to increase by 12.2 percent Y-o-Y (down 10.5 percent Q-o-Q) to Rs. 463.2 crore, according to KR Choksey.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 13.5 percent Y-o-Y (up 39.5 percent Q-o-Q) to Rs. 33.4 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Read More First Published on Jul 22, 2018 06:04 pm

3 Macroeconomic Trends You Need To Know Now

The stock market has been climbing the wall of worry since the end of June when significant technical support at the 200-day simple moving average was violated on the downside. Since the plunge, the Dow Jones Industrial Average has rocketed above both the 50 and 200-day simple moving averages appearing to be on its way to test resistance in the 250 zone. �

---Recommended Link---

20 Minutes To $40,653 Have you heard about "Social Security Insurance"? My clients are averaging $40,653 a year with this program. You can just copy them and make the same money they do. Why not? All it takes is 20 minutes. Click here to learn more.

The craziest thing is the stock market is moving higher in the face of extraordinary bearish pressures. �

A brewing trade war with China, daily shocks from the White House, and geopolitical tensions can't seem to damper the bullish enthusiasm.

How can this be possible?
The reason is there are major macroeconomic trends that are crushing the day-to-day bearish economic chaos. These trends are so dominant that there is little that can interfere outside of an extreme, unexpected systematic shock. This article will explain the three major economic trends fueling the super bull market.

1. Low Global Interest Rates
Interest rates are a prime driver of stock prices.� Globally, interest rates have been ultra-low as central banks scramble to help their economies prosper.� Prime examples include a zero percent rate with the European Central Bank, a negative 0.75% rate in the Swiss economy and a 2% rate in the United States. At latest count, 17 out of 26 major central banks lowered interest rates at their last change. �

Wait, isn't the world's largest economy raising rates now?

Yes, the United States has entered a regime of climbing rates.� However, the Federal Reserve is well aware of how interest rates affect the stock market and overall economy.

While it is generally believed that climbing interest rates are damaging to the stock market, the truth is very different.

Evidence shows that it is the velocity and surprise factor of interest rate hikes that control how the stock market reacts. Over the last six significant periods of raising rates, the S&P 500 rallied 23% on average, according to a CNBC study.

Remember, the Fed is raising rates since the economy is rapidly expanding.� A growing economy is the ultimate bullish scenario.� As stated earlier, the Fed is cautious with the gentle rate increases by telegraphing them well in advance. �

For now, the lowest global interest rate trend, despite the upticks, remains a tremendous tailwind for stocks. �

2. Economic Growth
Ever-improving technology combined with higher consumer demand across most sectors has triggered an era of robust economic growth.� Gross domestic product (GDP) is one way to measure growth.� It is viewed over time via trends rather than a simple snapshot.

Helping gain an overall perspective, TradingEconomics.com provides an excellent historical look at U.S. GDP: "GDP Growth Rate in the United States averaged 3.21 percent from 1947 until 2018, reaching an all-time high of 16.90 percent in the first quarter of 1950 and a record low of -10 percent in the first quarter of 1958."

While the growth rate from 2010 to 2016 averaged around 2%, it has jumped to an average of 2.5% over the last eighteen months.

While it is good to see the U.S. GDP trending higher, what has me most bullish is global growth in emerging markets

First, let's take a look at Asia. The Asian Development Bank (ADB) has kept its growth estimates at 5.9-6.0% despite the pending Chinese tariffs.� However, the ADB did add that clear risk exists should the tariff threat escalate. �

According to FMG Funds, the prime factor in the bullish global growth outlook from 2017 to 2018 is the emerging market sector. Emerging markets are projected to expand at an estimated 4.9% in 2018 and is forecast to reach 5% for 2019. Growth is predicted to continue into 2021 at 5.1%. �

Perhaps the most bullish factor for emerging markets growth is equity valuations.� Presently, emerging market equities boast a cyclically adjusted P/E multiple of around 12.8 times. The long-term average is 25 times -- indicating that emerging market stocks are trading at an incredible discount. When compared with developed markets, emerging markets trade at approximately 23% discount. I expect the discount to continue to attract significant institutional allocations pushing the sector higher over the long term.

Not only will the emerging markets growth trend continue to lead the global economy higher, but significant opportunities also exist in the sector for all investors!

3. Consumer Confidence
Consumer confidence is a prime driver of economic growth and stock prices.� Confident consumers spend money, which in turn fuels economic expansion, leading to the subsequent improvement in corporate bottom lines. Consumer spending is a huge factor, accounting for 70% of U.S. economic.

The metric soared to 130 in February 2018 marking the highest level in nearly two decades. The trend of consumer confidence riding near record highs is a macro trend that will continue to push stocks higher.

Risks To Consider: Despite my bullish optimism, no one knows what the future holds. Always use stops and position size wisely when investing!

Action To Take: Stay long and consider diversifying into emerging markets.

Editor's Note: Everyone knows that Social Security is in bad shape. But most people don't realize just how desperate the situation is... to fix Social Security benefits have to be cut by 22% immediately. Or payroll taxes have to jump by 32%. So you're facing pain whether you're working OR retired. But there's a way out. A program that can pay you $40,653 per year for the rest of your life. And it has nothing to do with the government. Check it out here.

VF (VFC) Upgraded at JPMorgan Chase & Co.

VF (NYSE:VFC) was upgraded by investment analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a research report issued on Monday, MarketBeat reports. The firm presently has a $78.00 target price on the textile maker’s stock. JPMorgan Chase & Co.’s target price indicates a potential downside of 11.87% from the company’s previous close.

A number of other research firms also recently weighed in on VFC. Bank of America upgraded VF from an “underperform” rating to a “buy” rating and set a $96.00 target price on the stock in a report on Friday, July 13th. Canaccord Genuity reiterated a “buy” rating and set a $92.00 target price on shares of VF in a report on Thursday, July 12th. Deutsche Bank began coverage on VF in a report on Thursday, July 12th. They set a “buy” rating and a $93.00 target price on the stock. UBS Group started coverage on VF in a report on Thursday, June 21st. They set a “neutral” rating and a $89.00 target price on the stock. Finally, Goldman Sachs Group started coverage on VF in a research note on Monday, June 25th. They issued a “buy” rating and a $96.00 price target on the stock. Ten investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $85.13.

Get VF alerts:

VF opened at $88.51 on Monday, MarketBeat reports. VF has a fifty-two week low of $55.51 and a fifty-two week high of $89.23. The company has a current ratio of 1.49, a quick ratio of 0.90 and a debt-to-equity ratio of 0.60. The company has a market cap of $33.66 billion, a price-to-earnings ratio of 29.70, a PEG ratio of 2.41 and a beta of 0.93.

VF (NYSE:VFC) last posted its earnings results on Friday, May 4th. The textile maker reported $0.67 earnings per share for the quarter, topping analysts’ consensus estimates of $0.65 by $0.02. VF had a return on equity of 34.05% and a net margin of 5.24%. The firm had revenue of $3.05 billion for the quarter, compared to the consensus estimate of $2.91 billion. During the same quarter in the prior year, the business earned $0.52 EPS. The business’s revenue for the quarter was up 21.8% on a year-over-year basis. analysts expect that VF will post 3.54 EPS for the current year.

In related news, VP Kevin Bailey sold 15,000 shares of the company’s stock in a transaction that occurred on Monday, May 14th. The stock was sold at an average price of $77.42, for a total value of $1,161,300.00. Following the transaction, the vice president now directly owns 54,571 shares of the company’s stock, valued at approximately $4,224,886.82. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Chairman Steven E. Rendle sold 74,180 shares of the company’s stock in a transaction that occurred on Friday, May 18th. The shares were sold at an average price of $80.12, for a total value of $5,943,301.60. Following the completion of the transaction, the chairman now directly owns 257,070 shares in the company, valued at $20,596,448.40. The disclosure for this sale can be found here. Insiders sold a total of 220,900 shares of company stock worth $17,948,688 in the last 90 days. 1.72% of the stock is currently owned by company insiders.

A number of hedge funds have recently added to or reduced their stakes in the stock. Berkshire Asset Management LLC PA bought a new position in VF in the 2nd quarter valued at approximately $232,000. Meag Munich Ergo Kapitalanlagegesellschaft MBH lifted its position in VF by 582.5% in the 2nd quarter. Meag Munich Ergo Kapitalanlagegesellschaft MBH now owns 42,996 shares of the textile maker’s stock valued at $3,538,000 after acquiring an additional 36,696 shares in the last quarter. Assenagon Asset Management S.A. bought a new position in VF in the 2nd quarter valued at approximately $1,496,000. Campbell & CO Investment Adviser LLC bought a new position in VF in the 2nd quarter valued at approximately $236,000. Finally, CX Institutional bought a new position in VF in the 2nd quarter valued at approximately $194,000.

VF Company Profile

V.F. Corporation engages in the design, production, procurement, marketing, and distribution of branded lifestyle apparel, footwear, and related products for men, women, and children in the Americas, Europe, and the Asia Pacific. It operates through four segments: Outdoor & Action Sports, Jeanswear, Imagewear, and Other.

Read More: Should you buy a closed-end mutual fund?

WD-40 Company Continues to Grow, but Perhaps Not Fast Enough

The message you get when you read through an investor presentation deck for the WD-40 Company (NASDAQ:WDFC) is growth. The North Star for management is to grow its revenue to $700 million annually by 2025 while maintaining its current margins. So when looking at the company's earnings reports, the first thing that any investor is going to look at is the revenue growth rate.

This past quarter, the WD-40 Company was able to post a significant uptick in sales from the prior quarter, but it is still well off the pace it needs to be at to meet management's goals. Here's a brief look at the company's most recent earnings numbers and how investors in this company may want to view the possibility of management not meeting this lofty sales goal.

Image source: The WD-40 Company

By the numbers Metric Q3 2018 Q2 2018 Q3 2017

Revenue	$107.0 million	$101.2 million	$98.1 million
Operating income	$22.3 million	$19.3 million	$20.6 million
Net income	$16.1 million	$14.8 million	$14.4 million
EPS	$1.15	$1.05	$1.02

Data source: WD-40 Company earnings release. EPS = Earnings per share.

I think it's fair to say that WD-40 is posting relatively healthy revenue growth. 9% year-over-year growth is certainly nothing to scoff at, especially for a business as mature and selling something as simple as WD-40. A lot of that gain, however, came from beneficial foreign currency exchange rates. Over the long haul, currency exchange rates tend to become a wash, so it's not great to rely on them for continued growth. Backing out the foreign exchange gain, revenue for the quarter was up 5% year over year. It's certainly better than the prior quarter's tepid growth numbers, but it is still well short of the numbers it has to put up if it wants to meet management's stated goal of $700 million in annual sales by 2025.

The one thing that has remained�consistent for some time is management's ability to generate earnings-per-share growth that outpaces revenue growth thanks to share repurchases. While the amount of stock repurchased in the quarter was rather low, the board approved another $75 million in purchases that will allow management to continue its trend of reducing its share count.�

WDFC Average Diluted Shares Outstanding (Quarterly). Data source:�YCharts.

What management had to say�

One of WD-40s most effective levers to pull when it comes to driving sales is to leverage the WD-40 brand into other products, which so far has been one of the more successful�aspects of the business. Here's CEO Garry Ridge discussing some of the high points in the company's sales numbers and some of the challenges it will face in the upcoming quarters. (You can check out a full transcript of the company's conference call here).

Our maintenance products delivered solid sales increases in the third quarter including 10 percent growth of WD-40 Multi-Use Product and 16 percent growth of WD-40 Specialist. Though fluctuating foreign currency exchange rates favorably impacted our sales results in the current quarter, we still saw a currency adjusted sales growth rate of 5 percent period-over-period.

Unfortunately, we are continuing to see the impact of higher commodity prices which have begun to deteriorate our gross margins in all three of our operating segments. To combat this margin pressure we have made some price increases to ensure our gross margin remains in-line with our 55/30/25 business model.

A quick note, the 55/30/25 refers to a management initiative that means a 55% gross margin, 30% cost of doing business, and 25% EBITDA margin.

WDFC price change. Data source:�YCharts.

Ten-second takeaway

There is an awful lot to like about WD-40 as a business. High margins, high rates of return, it's an asset-light business that doesn't require constant investment, and management has been adept at increasing shareholder value with regular dividend hikes and a reduced share count.�

One does have to wonder, though, if management is going to be able to meet these lofty revenue goals, and how much does it matter to the investment thesis for the company? While it isn't ideal that its growth lags the pace it needs to meet that revenue goal, maintaining a pace of 5%-6% sales growth paired with persistent share repurchases�should continue to produce double-digit earnings per share gains. For a mature business and product like WD-40, how much more can you really ask for?�

Spectrum Pharmaceuticals (SPPI) Rating Lowered to Hold at Zacks Investment Research

Spectrum Pharmaceuticals (NASDAQ:SPPI) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Thursday.

According to Zacks, “Spectrum Pharma is expected to file a BLA for its lead pipeline candidate, Rolontis in 2018. A potential approval will boost the prospect of the company. However, Spectrum has faced regulatory setbacks in the past including a CRL for Qapzola (bladder cancer) in the United States. Additional regulatory/development setbacks could affect the stock. However, out-licensing agreements for a number of products will allow Spectrum to focus on the development of its pipeline candidates. Spectrum’s shares have outperformed the industry in past one year. However, Spectrum's low product sales remain a cause of concern. Moreover, gaining market share is challenging for Spectrum as it competes with several companies with greater financial strength.”

Get Spectrum Pharmaceuticals alerts:

SPPI has been the subject of several other reports. TheStreet lowered Spectrum Pharmaceuticals from a “c-” rating to a “d+” rating in a research report on Friday, March 16th. ValuEngine raised Spectrum Pharmaceuticals from a “hold” rating to a “buy” rating in a research report on Monday, April 2nd. BidaskClub lowered Spectrum Pharmaceuticals from a “hold” rating to a “sell” rating in a research report on Wednesday, April 4th. Finally, HC Wainwright reaffirmed a “buy” rating and set a $33.00 target price on shares of Spectrum Pharmaceuticals in a research report on Friday, June 29th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Spectrum Pharmaceuticals has an average rating of “Buy” and an average price target of $27.20.

Shares of Spectrum Pharmaceuticals opened at $22.14 on Thursday, MarketBeat.com reports. The firm has a market cap of $2.22 billion, a P/E ratio of -20.44 and a beta of 1.98. Spectrum Pharmaceuticals has a 12-month low of $7.12 and a 12-month high of $23.50.

Spectrum Pharmaceuticals (NASDAQ:SPPI) last announced its earnings results on Thursday, May 3rd. The biotechnology company reported ($0.16) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.35) by $0.19. The business had revenue of $30.50 million during the quarter, compared to analyst estimates of $25.68 million. Spectrum Pharmaceuticals had a negative return on equity of 29.47% and a negative net margin of 64.39%. Spectrum Pharmaceuticals’s revenue for the quarter was up 4.8% compared to the same quarter last year. During the same period last year, the company earned ($0.14) EPS. equities research analysts anticipate that Spectrum Pharmaceuticals will post -0.91 earnings per share for the current year.

In other Spectrum Pharmaceuticals news, Director Rajesh C. Md Shrotriya sold 12,300 shares of the stock in a transaction dated Monday, April 9th. The stock was sold at an average price of $15.01, for a total transaction of $184,623.00. Following the completion of the sale, the director now directly owns 200,652 shares in the company, valued at approximately $3,011,786.52. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Rajesh C. Md Shrotriya sold 30,000 shares of the stock in a transaction dated Wednesday, April 11th. The stock was sold at an average price of $20.30, for a total value of $609,000.00. Following the sale, the director now owns 200,652 shares of the company’s stock, valued at $4,073,235.60. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 646,417 shares of company stock valued at $11,440,813. 9.35% of the stock is owned by corporate insiders.

Institutional investors have recently modified their holdings of the business. Teacher Retirement System of Texas acquired a new stake in shares of Spectrum Pharmaceuticals in the 4th quarter valued at about $541,000. California Public Employees Retirement System grew its stake in shares of Spectrum Pharmaceuticals by 31.1% in the 4th quarter. California Public Employees Retirement System now owns 204,113 shares of the biotechnology company’s stock valued at $3,868,000 after buying an additional 48,413 shares during the period. Swiss National Bank grew its stake in shares of Spectrum Pharmaceuticals by 7.3% in the 4th quarter. Swiss National Bank now owns 144,000 shares of the biotechnology company’s stock valued at $2,729,000 after buying an additional 9,800 shares during the period. Wells Fargo & Company MN grew its stake in shares of Spectrum Pharmaceuticals by 2.6% in the 4th quarter. Wells Fargo & Company MN now owns 973,812 shares of the biotechnology company’s stock valued at $18,454,000 after buying an additional 24,522 shares during the period. Finally, The Manufacturers Life Insurance Company grew its stake in shares of Spectrum Pharmaceuticals by 10.7% in the 4th quarter. The Manufacturers Life Insurance Company now owns 66,341 shares of the biotechnology company’s stock valued at $1,257,000 after buying an additional 6,396 shares during the period. Hedge funds and other institutional investors own 77.15% of the company’s stock.

About Spectrum Pharmaceuticals

Spectrum Pharmaceuticals, Inc develops and commercializes oncology and hematology drug products. The company markets six drug products, including FUSILEV for patients with metastatic colorectal cancer and rescue after high-dose methotrexate therapy in osteosarcoma, and to diminish toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosage of folic acid antagonists; FOLOTYN, a folate analogue metabolic inhibitor for peripheral T-cell lymphoma (PTCL); ZEVALIN injection for patients with B-cell non-Hodgkin's lymphoma; MARQIBO, a sphingomyelin/cholesterol liposome-encapsulated formulation for adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia; BELEODAQ injection for PTCL; and EVOMELA for use as a conditioning treatment prior to autologous stem cell transplant in multiple myeloma patients.

Get a free copy of the Zacks research report on Spectrum Pharmaceuticals (SPPI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top China Stocks To Watch For 2019

tags:SINA,FMCN,BIDU,TISA, Related FXI China's Manufacturing Sector Just Hit A 51-Month Low What If S&P Downgraded China? The King Of All Reversal Trades Has Arrived (Seeking Alpha)

This weekend marks a crucial moment for the Chinese government, as it is set to unveil its new five-year economic plan during its annual session of the national legislature. The world will be paying especially close attention to this year’s plan. Fears surrounding the stability of China’s economy and the durability of China’s economic growth have been the driving force behind elevated global economic fears in recent months.

Top China Stocks To Watch For 2019: Sina Corporation(SINA)

Advisors' Opinion:

• [By Leo Sun]

  But as the U.S. market remains stuck in neutral, Chinese tech stocks have thrived, sparked by impressive growth figures and their detachment from U.S.-centered issues. Let's examine three stocks in that industry which have already rallied more than 30% this month -- Baozun (NASDAQ:BZUN), Weibo (NASDAQ:WB), and SINA (NASDAQ:SINA).

• [By Ethan Ryder]

  Eagle Global Advisors LLC decreased its position in Sina Corp (NASDAQ:SINA) by 1.8% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 84,875 shares of the technology company’s stock after selling 1,595 shares during the period. Eagle Global Advisors LLC owned about 0.12% of Sina worth $8,850,000 at the end of the most recent quarter.

• [By Steve Symington]

  Shares of SINA Corp. (NASDAQ:SINA) were down 10.2% as of 3:30 p.m. EDT Wednesday despite strong first-quarter 2018 results from the Chinese internet media company.

• [By Ethan Ryder]

  Get a free copy of the Zacks research report on SINA (SINA)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Leo Sun]

  Shares of Weibo (NASDAQ:WB) and its parent SINA (NASDAQ:SINA) tumbled 14% and 10%, respectively, after posting their first quarter results on May 9. The sell-off was surprising, since both companies easily beat analyst expectations.

Top China Stocks To Watch For 2019: Focus Media Holding Limited(FMCN)

Advisors' Opinion:

• [By Stephan Byrd]

  An issue of Focus Media Holding Limited (NASDAQ:FMCN) debt fell 1.1% against its face value during trading on Tuesday. The debt issue has a 7.5% coupon and is set to mature on April 1, 2025. The debt is now trading at $97.63 and was trading at $98.50 last week. Price changes in a company’s debt in credit markets sometimes anticipate parallel changes in its stock price.

Top China Stocks To Watch For 2019: Baidu Inc.(BIDU)

Advisors' Opinion:

• [By Danny Vena]

  Chinese streaming giant iQiyi Inc. (NASDAQ:IQ)�was recently spun off from China's search leader Baidu Inc. (NASDAQ:BIDU), raising an estimated $2.25 billion in the process.�

• [By Dan Caplinger]

  The stock market didn't see much volatility on Friday, with most major benchmarks finishing the session very close to where they had started. Without much in the way of market-moving news on the national or global front, most investors instead paid attention to the cross-currents involved with monthly options expirations. Some other parts of the financial markets were more interesting, with bond yields easing a bit lower after their big upward push earlier in the week and oil prices taking a break from their recent surge. Yet some individual companies suffered from bad news that sent their shares lower. Baidu (NASDAQ:BIDU), GameStop (NYSE:GME), and Opko Health (NASDAQ:OPK) were among the worst performers on the day. Here's why they did so poorly.

• [By Motley Fool Staff]

  In this segment from the Motley Fool Money podcast, host Chris Hill is joined by Jason Moser of Million Dollar Portfolio, David Kretzmann of Hidden Gems Canada, and Aaron Bush of Motley Fool Rule Breakers to address a listener's question: What's the best Chinese stock for long-term investors? The team likes Baidu (NASDAQ:BIDU), commonly referred to as "the Google of China," as well as Tencent (NASDAQOTH:TCEHY), the company behind the extremely popular messaging and social media app WeChat.

• [By Chris Hill]

  Hill:�We'll stick with video for a minute or two longer. Now that�iQiyi�is public --�you've talked about this before, is this of interest to you? Is this a stock you've already bought, or it's on the watch list? And for those who don't know, iQiyi was�essentially spun out of Baidu (NASDAQ:BIDU). So, the Google of China spins out the Netflix of China. And as you said before, it seems like, if nothing else, it's a win for Baidu shareholders, because Baidu still has the ownership stake.

• [By Rick Munarriz]

  Shares of Baidu�(NASDAQ:BIDU)�were hitting all-time highs last week, but after they tumbled 15% over the past three trading days, it's easy to wonder if they will be revisiting Wednesday's high-water mark anytime soon. China's leading search engine has seen its stock come under pressure after its COO announced late last week that he would be stepping down.

Top China Stocks To Watch For 2019: Top Image Systems Ltd.(TISA)

Advisors' Opinion:

• [By Ethan Ryder]

  Get a free copy of the Zacks research report on Top Image Systems (TISA)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Penny Stocks To Watch For 2019

tags:UMH,RDC,CNR,RMCF,FFNW,CPHI,

Vancouver-based mineral exploration and development company Kootenay Zinc Corp. (OTCQB:KTNNF)(CSE:ZNK.CN)(CSE:ZNK)(FRANKFURT:KYH) is currently in the process of developing a massive new greenfield mining megaproject that if successful would trigger a significant adjustment in the configuration of North American zinc production. Dubbed ��Sully�� in homage to the nearby Sullivan Deposit��itself an iconic Canadian mine and one of the world��s most productive of its kind for over a century��the new project would give Kootenay exclusive rights to begin operations to extract one of the top-performing global commodities in recent years on a sprawling 1,375ha site. Located just 30km away from the original Sullivan Deposit, Sully exhibits promising physical anomalies of the same order as those observed at the original Sullivan mine that point to massive sedimentary exhalative (SEDEX) deposits, so a positive outlook on this penny stock is not without merit.

Hot Penny Stocks To Watch For 2019: UMH Properties Inc.(UMH)

Advisors' Opinion:

• [By Lisa Levin]

  Wednesday afternoon, the real estate shares surged 0.56 percent. Meanwhile, top gainers in the sector included Armada Hoffler Properties, Inc. (NYSE: AHH), up 3 percent, and UMH Properties, Inc. (NYSE: UMH) up 3 percent.

• [By Joseph Griffin]

  WINTON GROUP Ltd bought a new stake in UMH PROPERTIES/SH SH (NYSE:UMH) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 86,705 shares of the real estate investment trust’s stock, valued at approximately $1,163,000. WINTON GROUP Ltd owned about 0.24% of UMH PROPERTIES/SH SH as of its most recent SEC filing.

Hot Penny Stocks To Watch For 2019: Rowan Companies Inc.(RDC)

Advisors' Opinion:

• [By Lisa Levin]

  Check out these big penny stock gainers and losers

  Losers MDC Partners Inc. (NASDAQ: MDCA) fell 23.4 percent to $5.25 in pre-market trading after a first-quarter earnings miss. Hudson Technologies Inc. (NASDAQ: HDSN) shares fell 15.1 percent to $3.48 in pre-market trading after the company reported downbeat Q1 earnings. Nuance Communications, Inc. (NASDAQ: NUAN) fell 14 percent to $13.15 in pre-market trading after the company posted downbeat Q2 earnings and lowered FY18 organic growth guidance. Myomo, Inc. (NYSE: MYO) fell 13.2 percent to $3.10 in pre-market trading after reporting downbeat quarterly results. Rowan Companies plc (NYSE: RDC) shares fell 10.7 percent to $14.13 in pre-market trading after climbing 8.50 percent on Wednesday. BT Group plc (NYSE: BT) fell 9 percent to $14.80 in pre-market trading after the company reported Q4 results and announced plans to cut 13,000 jobs over the next three years. Exelixis, Inc. (NASDAQ: EXEL) fell 8.3 percent to $19.90 in pre-market trading after the company disclosed that IMblaze370 Phase 3 pivotal trial of atezolizumab and cobimetinib in patients with heavily pretreated locally advanced or metastatic colorectal cancer did not meet primary endpoint. Infinera Corporation (NASDAQ: INFN) fell 8.2 percent to $10.80 in pre-market trading after reporting Q1 results. Synaptics, Incorporated (NASDAQ: SYNA) shares fell 7.4 percent to $43.00 in pre-market trading. Synaptics reported better-than-expected earnings for its third quarter, while sales missed estimates. Randgold Resources Limited (NASDAQ: GOLD) shares fell 7.4 percent to $76.23 in pre-market trading after reporting Q1 earnings. Integra LifeSciences Holdings Corporation (NASDAQ: IART) shares fell 7 percent to $59.36 in pre-market trading. Integra LifeSciences priced its 5.25 million share public offering of common stock at $58.50 per share. Array BioPharma Inc. (NASDAQ: ARRY) shares fell 6.9 percent to $12.75 in pre-m
• [By Max Byerly]

  Shares of Rowan Companies PLC (NYSE:RDC) rose 0.8% during mid-day trading on Thursday . The company traded as high as $16.36 and last traded at $16.09. Approximately 144,835 shares changed hands during mid-day trading, a decline of 94% from the average daily volume of 2,492,971 shares. The stock had previously closed at $16.22.

• [By Shane Hupp]

  California Public Employees Retirement System reduced its position in Rowan Companies PLC (NYSE:RDC) by 5.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 656,438 shares of the oil and gas company’s stock after selling 41,386 shares during the quarter. California Public Employees Retirement System owned 0.52% of Rowan Companies worth $7,575,000 as of its most recent SEC filing.

Hot Penny Stocks To Watch For 2019: China Metro-Rural Holdings Limited(CNR)

Advisors' Opinion:

• [By Joseph Griffin]

  Shares of Canadian National Railway (TSE:CNR) (NYSE:CNI) have been given an average recommendation of “Buy” by the eleven research firms that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is C$109.36.

• [By Shane Hupp]

  Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp cut its position in Canadian National Railway (NYSE:CNI) (TSE:CNR) by 21.1% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,956,400 shares of the transportation company’s stock after selling 522,300 shares during the period. Canadian National Railway accounts for about 1.7% of Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp’s investment portfolio, making the stock its 7th biggest position. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp owned 0.27% of Canadian National Railway worth $184,215,000 at the end of the most recent reporting period.

• [By Shane Hupp]

  Wall Street analysts expect that Canadian National Railway (NYSE:CNI) (TSE:CNR) will announce $1.02 earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Seven analysts have provided estimates for Canadian National Railway’s earnings, with the highest EPS estimate coming in at $1.06 and the lowest estimate coming in at $0.97. Canadian National Railway reported earnings per share of $1.00 in the same quarter last year, which would suggest a positive year over year growth rate of 2%. The company is expected to announce its next quarterly earnings results on Tuesday, July 24th.

Hot Penny Stocks To Watch For 2019: Rocky Mountain Chocolate Factory Inc.(RMCF)

Advisors' Opinion:

• [By Ethan Ryder]

  Rocky Mountain Chocolate Factory (NASDAQ: RMCF) and Tootsie Roll Industries (NYSE:TR) are both small-cap retail/wholesale companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, dividends and analyst recommendations.

• [By Max Byerly]

  Rocky Mountain Chocolate Factory (NASDAQ: RMCF) and Tootsie Roll Industries (NYSE:TR) are both small-cap retail/wholesale companies, but which is the better investment? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.

Hot Penny Stocks To Watch For 2019: First Financial Northwest Inc.(FFNW)

Advisors' Opinion:

• [By Ethan Ryder]

  Get a free copy of the Zacks research report on First Financial Northwest (FFNW)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Logan Wallace]

  Get a free copy of the Zacks research report on First Financial Northwest (FFNW)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Penny Stocks To Watch For 2019: China Pharma Holdings Inc.(CPHI)

Advisors' Opinion:

• [By Logan Wallace]

  These are some of the news headlines that may have impacted Accern Sentiment’s scoring:

  Get Scynexis alerts: Steady Activities: SCYNEXIS, Inc. (NASDAQ:SCYX), LPL Financial Holdings Inc. (NASDAQ:LPLA) (oracleexaminer.com) Do Analysts Think You Should Buy �� SCYNEXIS Inc (NASDAQ: SCYX) (stockspen.com) Notable Runner: SCYNEXIS, Inc. (SCYX) (nasdaqplace.com) Most Active Stocks Now: SCYNEXIS, Inc. (NASDAQ:SCYX), China Pharma Holdings, Inc. (NYSE:CPHI), Kala … (journalfinance.net) Overview on price to free cash flow: SCYNEXIS, Inc. (NASDAQ:SCYX), InfuSystem Holdings Inc. (NYSE:INFU) (stocksnewspoint.com)

  Several research analysts have recently issued reports on the company. Roth Capital assumed coverage on Scynexis in a research note on Tuesday, May 8th. They set a “buy” rating and a $6.00 price target for the company. Seaport Global Securities assumed coverage on Scynexis in a research note on Tuesday, April 10th. They set a “buy” rating and a $4.00 price target for the company. Zacks Investment Research raised Scynexis from a “hold” rating to a “buy” rating and set a $1.25 price target for the company in a research note on Tuesday, May 8th. HC Wainwright assumed coverage on Scynexis in a research note on Monday, May 7th. They set a “buy” rating and a $5.00 price target for the company. Finally, ValuEngine raised Scynexis from a “sell” rating to a “hold” rating in a research note on Wednesday, May 2nd. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the stock. Scynexis currently has an average rating of “Buy” and an average target price of $4.45.

Accenture Plc (ACN) Chairman & CEO Pierre Nanterme Sold $5.3 million of Shares

Chairman & CEO of Accenture Plc (NYSE:ACN) Pierre Nanterme sold 32,376 shares of ACN on 07/02/2018 at an average price of $162.39 a share. The total sale was $5.3 million.

Accenture PLC is a professional service company. It provides consulting, technology and outsourcing services to Communications, Media and Technology, Financial services, Health and Public service, Products and Resources segments. Accenture PLC has a market cap of $104.77 billion; its shares were traded at around $163.34 with a P/E ratio of 26.18 and P/S ratio of 2.65. The dividend yield of Accenture PLC stocks is 1.62%. Accenture PLC had annual average EBITDA growth of 10.00% over the past ten years. GuruFocus rated Accenture PLC the business predictability rank of 4.5-star.

CEO Recent Trades:

Chairman & CEO Pierre Nanterme sold 32,376 shares of ACN stock on 07/02/2018 at the average price of $162.39. The price of the stock has increased by 0.59% since.

Directors and Officers Recent Trades:

Group Chief Exec-Products 't Noordende Alexander M Van sold 6,500 shares of ACN stock on 07/02/2018 at the average price of $162.37. The price of the stock has increased by 0.6% since.Grp Chief Exec-Com, Med & Tech Robert E Sell sold 3,750 shares of ACN stock on 07/02/2018 at the average price of $162.34. The price of the stock has increased by 0.62% since.Group Chief Exec-Resources Jean-marc Ollagnier sold 1,439 shares of ACN stock on 07/02/2018 at the average price of $162.39. The price of the stock has increased by 0.59% since.General Counsel and CCO Chad T Jerdee sold 1,141 shares of ACN stock on 07/02/2018 at the average price of $162.3. The price of the stock has increased by 0.64% since.COO Johan Deblaere sold 5,000 shares of ACN stock on 07/02/2018 at the average price of $162.36. The price of the stock has increased by 0.6% since.

For the complete insider trading history of ACN, click here

.

Navios Maritime Midstream Partners (NAP) Lowered to Strong Sell at ValuEngine

ValuEngine lowered shares of Navios Maritime Midstream Partners (NYSE:NAP) from a sell rating to a strong sell rating in a research note published on Monday morning.

NAP has been the topic of several other research reports. JPMorgan Chase & Co. lowered Navios Maritime Midstream Partners from a neutral rating to an underweight rating and set a $7.00 price objective on the stock. in a research note on Friday, March 23rd. TheStreet lowered Navios Maritime Midstream Partners from a c rating to a d+ rating in a research note on Monday, May 7th. Citigroup dropped their price objective on Navios Maritime Midstream Partners from $6.50 to $4.50 and set a neutral rating on the stock in a research note on Friday, May 4th. Finally, Zacks Investment Research upgraded Navios Maritime Midstream Partners from a sell rating to a hold rating in a research note on Wednesday, April 25th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the company’s stock. The stock currently has an average rating of Hold and a consensus price target of $5.25.

Get Navios Maritime Midstream Partners alerts:

NYSE:NAP opened at $3.60 on Monday. The company has a debt-to-equity ratio of 0.90, a quick ratio of 5.88 and a current ratio of 5.88. The company has a market capitalization of $80.15 million, a price-to-earnings ratio of 5.14 and a beta of 1.19. Navios Maritime Midstream Partners has a 12-month low of $3.26 and a 12-month high of $10.70.

Navios Maritime Midstream Partners (NYSE:NAP) last released its quarterly earnings data on Thursday, May 3rd. The shipping company reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.05). The business had revenue of $19.78 million during the quarter, compared to the consensus estimate of $19.45 million. Navios Maritime Midstream Partners had a negative net margin of 20.37% and a positive return on equity of 5.21%. equities research analysts predict that Navios Maritime Midstream Partners will post 0.69 EPS for the current fiscal year.

An institutional investor recently raised its position in Navios Maritime Midstream Partners stock. Virtu Financial LLC lifted its position in shares of Navios Maritime Midstream Partners LP (NYSE:NAP) by 139.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 34,693 shares of the shipping company’s stock after purchasing an additional 20,183 shares during the period. Virtu Financial LLC owned 0.16% of Navios Maritime Midstream Partners worth $330,000 as of its most recent filing with the Securities and Exchange Commission. Institutional investors own 6.76% of the company’s stock.

Navios Maritime Midstream Partners Company Profile

Navios Maritime Midstream Partners L.P. owns, operates, and acquires crude oil tankers, refined petroleum product tankers, chemical tankers, and liquefied petroleum gas tankers. The company provides seaborne shipping services through its vessels under long-term employment contracts to international oil companies, refiners, and large vessel operators.

To view ValuEngine’s full report, visit ValuEngine’s official website.